Heart Attack (Myocardial Infarction)
- What is Heart Attack?
- Statistics on Heart Attack
- Risk Factors for Heart Attack
- Progression of Heart Attack
- How is Heart Attack Diagnosed?
- Prognosis of Heart Attack
- How is Heart Attack Treated?
- Heart Attack References
- Drugs/Products Associated with Heart Attack
What is Heart Attack?

3D Animation on
Myocardial Infarction
This animation brought to you by Blausen Medical Communications.
Contact Andrew Walbank.
Statistics on Heart Attack?
Coronary artery disease is the most common cause of death in the Western world, and most of these deaths are due to myocardial infarction (heart attack). In Australia, approximately 21% of all deaths are due to coronary heart disease, and there are 605 coronary events per 100,000 people aged 40-90 years.
Myocardial infarction is a common condition. There are thousands of new cases every year. It is a serious and life-threatening condition. Around one quarter of patients die from the acute event, half of these before the hospital is reached. Survivors have a higher risk of recurrent heart attacks or cardiac death, and a further 10% die within two years. Only 50% of initial survivors are alive at 10 years.
Men
Men have a higher risk of heart attacks and other acute coronary events, and males are more likely to be affected at a younger age. Around three quarters of heart attacks are in male patients. Males and females older than 70 years of age are equally affected.
Women
Women before menopause have lower rates of heart attack, which may be due to the effects of oestrogen (oestrogen reduces the build up of plaques in blood vessels). However, the incidence of heart attacks increases dramatically in women aged 60-70 years to match that of men.
Women have higher mortality and hospitalisation rates from heart attacks, perhaps partly because women receive less aggressive in-hospital therapy for acute myocardial infarction than men. The reasons for this are not clear, but may be due to poor diagnosis and lack of knowledge about the benefits of treatment in women.
Risk Factors for Heart Attack
![]() 3D Animation on Plaque Rupture This animation brought to you by Blausen Medical Communications. Contact Andrew Walbank. |
There are many risk factors for coronary artery disease:
- Hypercholesterolaemia (elevated levels of cholesterol in the blood) plays a central role in the development of plaques.
- Increased age and male gender.
- Family history of coronary artery disease.
- Smoking: Risk is directly related to the number of cigarettes smoked.
- Diabetes mellitus: Abnormal blood sugar levels promote vascular damage and the development of plaques.
- Hypertension: High blood pressure promotes artery damage, which may initiate or exacerbate atherosclerosis, causing plaque rupture.
Other, less important risk factors (so-called soft factors) include:
- Stress/anxious personality
- Obesity
- Alcohol consumption
Virtual Medical Centre Video
Watch a video on Cardiovascular Disease Prevention

This information will be collected for educational purposes, however it will remain anonymous.
Progression of Heart Attack
Coronary atherosclerosis leads to narrowing of the arteries and impairment of blood supply to the heart muscle. Early in the disease process, this causes angina pectoris, or chest pain experienced when the heart muscle's demand for blood is increased (e.g. during exercise). Later in the disease process, the artery may become completely blocked, usually due to a piece of plaque breaking off, moving downstream and obstructing a smaller artery. This causes myocardial infarction and results in permanent damage to the heart muscle. Even if blood flow to the heart muscle is not physically impaired, ischaemia can still occur when, for example, the blood's ability to carry oxygen is impaired (e.g. anaemia) or when the heart's requirements are significantly increased (e.g. during exercise and ventricular hypertrophy).
How is Heart Attack Diagnosed?
- ECG
- Chest x-ray
- Blood tests to assess kidney function should be carried out
Prognosis of Heart Attack
Myocardial infarctions (heart attacks) are a serious event: approximately 25% of patients die from the initial event - that is, they may die before reaching hospital, or in the first day or so. Of the rest, 25% will die within the next two years, usually due to recurrent MI or complications. About 50% of the initial survivors are alive after 10 years. The prognosis is better for younger patients with less concurrent medical problems.
How is Heart Attack Treated?
- Management is on a coronary care unit.
- Aspirin 300mg is given.
- High flow oxygen.
- Pain management with morphine.
- Heart rate is controlled using a beta-blocker (if no signs of heart failure or heart block).
- If within 12 hours and no contraindications (stroke or active bleeding in the last two months) thrombolytic therapy or angiography with angioplasty may be considered.
- Management of common complications of MI such as heart failure, pericarditis and arrhythmias.
Long term management is similar to that for angina (if not already instigated). This includes aspirin therapy, beta-blockers, and cholesterol lowering if required. Maintaining a healthy diet, quitting smoking, exercise and weight reduction (if overweight) are important aspects of long-term treatment to reduce the risk of recurrent heart attack.
Heart Attack References
- Clarke K, Gray D, Keating N, Hampton J. Do women with acute myocardial infarction receive the same treatment as men? BMJ 1994; 309: 563-6.
- Fenton D, Stahmer S. Myocardial Infarction, eMedicine, Web MD, 2006. Available from URL: http://www.emedicine.com/emerg/topic327.htm.
- Gan S, Beaver S, Houck P, MacLehose R, Lawson H, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. NEJM 2000; 343(1): 8-15.
- Garas S, Zafari A, Myocardial Infarction, eMedicine, Web MD, 2006. Available from URL: http://www.emedicine.com/med/topic1567.htm.
- Hurst's The Heart 8th Edition, McGraw Hill, 1994.
- Kumar and Clark. Clinical Medicine 4th Edition, W.B Saunders, 1998.
- Martur S, Epidemic of coronary heart disease and its treatment in Australia, AIHW 2002, cat. no. CVD 21.
- Mehta S, Eagle K. Secondary prevention in acute myocardial infarction. BMJ 1998; 316: 838-42.
Symptoms of This Disease:
Treatments Used in This Disease:
- LDL (Low Density Lipoprotein) Cholesterol Lowering
- Heart Transplant
- Angiotensin II Receptor Blockers (ARB)
- Angiotensin-converting Enzyme Inhibitors (ACE inhibitors, ACEi)
Drugs/Products Used in the Treatment of This Disease:
- Actilyse 50 mg (Alteplase)
- Adrenaline Injection (Adrenaline acid tartrate)
- Amprace (Enalapril maleate)
- Atenolol (Terry White Chemists) (Atenolol)
- Chem mart Sotalol (Sotalol hydrochloride)
- Clexane (Enoxaparin sodium)
- Disprin (Aspirin)
- Dobutamine Hydrochloride Injection (Dobutamine hydrochloride)
- Dobutamine Hydrochloride Injection (DBL) (Dobutamine hydrochloride)
- Dopamine Concentrate (Sterile) (DBL) (Dopamine hydrochloride)
- Frusemide-BC (Frusemide)
- Inspra (Eprelenone)
- Lanoxin (Digoxin)
- Lignocaine Hydrochloride Injection (Lignocaine hydrochloride)
- Lignocaine Injection (Lignocaine hydrochloride)
- Metoprolol (Terry White Chemists) (Metoprolol tartrate)
- Ramace (Ramipril)
- Rapilysin (Reteplase)
- Streptase (Streptokinase)
Article Dates:
|
|
Current Sponsors
Current Sponsors
|
Please be aware that we do not give advice on your individual medical condition, Information on this site must be discussed with your treating doctor. Virtual Medical Centre © 2002 - 2010 | Privacy Policy Last updated 30 Jul 2010 |
||
| ^ Back to Top | ||







